Jade Biosciences Ord Shs
JBIO15.320USD
+0.930+6.46%
Close 02/06, 16:00（ET）Quotes delayed by 15 min
499.84MMarket Cap
LossP/E TTM
More Details of Company
Jade Biosciences Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Jade Biosciences Ord Shs
Name
Name/Position
Position
Shareholding
Change
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+43.00%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Dr. Ralph Niven, Ph.D.
Dr. Ralph Niven, Ph.D.
Chief Scientific Officer
Chief Scientific Officer
--
--
Dr. Marinus Verwijs, Ph.D.
Dr. Marinus Verwijs, Ph.D.
Chief Technical Officer
Chief Technical Officer
--
--
Mr. Stephen K. Yu
Mr. Stephen K. Yu
Senior Vice President - Quality
Senior Vice President - Quality
--
--
Mr. Donald J. (Don) Santel
Mr. Donald J. (Don) Santel
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Dr. Benjamin T. Dake, Ph.D.
Dr. Benjamin T. Dake, Ph.D.
President, Chief Operating Officer, Secretary
President, Chief Operating Officer, Secretary
505.00
+43.00%
Mr. Timothy P. Noyes
Mr. Timothy P. Noyes
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Mark Iwicki
Mr. Mark Iwicki
Independent Director
Independent Director
--
--
Ms. Allison Dorval, CPA
Ms. Allison Dorval, CPA
Independent Director
Independent Director
--
--
Dr. Joshua Resnick, M.D.
Dr. Joshua Resnick, M.D.
Independent Director
Independent Director
--
--
Dr. David S. Grayzel, M.D.
Dr. David S. Grayzel, M.D.
Independent Director
Independent Director
--
--
Revenue Breakdown
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
By Business
By Region
Relevant data have not been disclosed by the company yet.
Shareholding Stats
Updated: Fri, Jan 30
Updated: Fri, Jan 30
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.71%
Fairmount Funds Management LLC
9.23%
VR Adviser, LLC
6.53%
RA Capital Management, LP
6.52%
Janus Henderson Investors
6.21%
Other
61.79%
Shareholders
Shareholders
Proportion
Fidelity Management & Research Company LLC
9.71%
Fairmount Funds Management LLC
9.23%
VR Adviser, LLC
6.53%
RA Capital Management, LP
6.52%
Janus Henderson Investors
6.21%
Other
61.79%
Shareholder Types
Shareholders
Proportion
Hedge Fund
20.36%
Investment Advisor
19.37%
Venture Capital
18.79%
Investment Advisor/Hedge Fund
17.29%
Private Equity
3.94%
Individual Investor
0.99%
Research Firm
0.47%
Bank and Trust
0.08%
Insurance Company
0.03%
Other
18.68%
Institutional Shareholding
Updated: Wed, Jan 21
Updated: Wed, Jan 21
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q4
161
38.26M
85.14%
--
2025Q4
223
39.61M
80.32%
+323.28K
2025Q3
219
31.65M
77.53%
-1.17M
2025Q2
222
32.33M
102.43%
+21.99M
2025Q1
207
926.72K
111.95%
-347.50K
2024Q4
207
879.69K
106.31%
-203.28K
2024Q3
202
808.07K
98.05%
-248.23K
2024Q2
199
794.81K
96.63%
-106.00K
2024Q1
171
831.84K
104.51%
-50.52K
2023Q4
165
824.02K
104.24%
-56.42K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Fidelity Management & Research Company LLC
4.79M
9.71%
+53.40K
+1.13%
Sep 30, 2025
Fairmount Funds Management LLC
4.55M
9.23%
--
--
Dec 17, 2025
VR Adviser, LLC
3.22M
6.53%
--
--
Dec 17, 2025
RA Capital Management, LP
3.21M
6.52%
--
--
Dec 17, 2025
Janus Henderson Investors
3.06M
6.21%
--
--
Dec 17, 2025
Deep Track Capital LP
2.28M
4.62%
-229.41K
-9.14%
Sep 30, 2025
The Vanguard Group, Inc.
1.73M
3.5%
-80.84K
-4.47%
Sep 30, 2025
BlackRock Institutional Trust Company, N.A.
1.96M
3.98%
+401.34K
+25.73%
Sep 30, 2025
Versant Ventures
1.53M
3.09%
--
--
Sep 30, 2025
RTW Investments L.P.
1.45M
2.94%
--
--
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.08%
iShares Russell 2000 Value ETF
0.03%
Global X Russell 2000 ETF
0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
0.02%
ProShares Hedge Replication ETF
0.02%
ProShares UltraPro Russell2000
0.01%
Proshares Ultra Russell 2000
0.01%
iShares Russell 2000 ETF
0.01%
iShares Russell 3000 ETF
0%
iShares Russell 2000 Growth ETF
0%
View more
iShares Micro-Cap ETF
Proportion0.08%
iShares Russell 2000 Value ETF
Proportion0.03%
Global X Russell 2000 ETF
Proportion0.02%
Invesco Russell 2000 Dynamic Multifactor ETF
Proportion0.02%
ProShares Hedge Replication ETF
Proportion0.02%
ProShares UltraPro Russell2000
Proportion0.01%
Proshares Ultra Russell 2000
Proportion0.01%
iShares Russell 2000 ETF
Proportion0.01%
iShares Russell 3000 ETF
Proportion0%
iShares Russell 2000 Growth ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Splits
Date
Ex-dividend Date
Type
Ratio
Apr 21, 2025
Merger
35→1
Date
Ex-dividend Date
Type
Ratio
Apr 21, 2025
Merger
35→1
